ÂÜÀòÂÒÂ×

Sue Naim has over two decades of extensive experience in clinical operations and outsourcing within the pharmaceutical industry. Currently serving as Senior Vice President at ALX Oncology since July 2020, Naim has held multiple leadership roles, including Vice President and Executive Director. Prior to ALX Oncology, Naim worked at Astex Pharmaceuticals from June 2012 to June 2020, advancing through positions such as Senior Director and Director of Clinical Operations. Naim's earlier career includes significant roles at Metabolex, Cell Genesys, Mentor, ICN Pharmaceuticals, and Irvine Scientific, where responsibilities encompassed clinical monitoring, contract negotiations, and collaboration with research teams. Naim holds a degree from UCLA.